earnings
NE
NASDAQ · NERV
Minerva Neurosciences, Inc.
Healthcare · Biotechnology
$2.35
Up+$0.10 (+4.05%)
Updated Nov 3, 2026, 3:33 PM
SID Score
2.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 28.95M
- P/E ratio
- 2.79
- Dividend yield
- 0.00%
- 52-week range
- $1.96 – $8.80
- Volume
- 230.65K
- Avg. volume
- 3.01M
Price performance · NERV
NERV price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 2, 2026
NERV closed at $2.35 after 21 trading sessions, down 29.37% for the selected period.
- Last close
- $2.35
- Period change
- -29.37%
- Period low
- $2.20
- Period high
- $3.43
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 2, 2026 | $2.34 | $2.51 | $2.30 | $2.345 | 230.65K |
| Oct 30, 2026 | $2.23 | $2.32 | $1.96 | $2.32 | 394.69K |
| Oct 29, 2026 | $2.25 | $2.445 | $2.20 | $2.24 | 267.56K |
| Oct 28, 2026 | $2.23 | $2.27 | $2.12 | $2.21 | 204.4K |
| Oct 27, 2026 | $2.25 | $2.335 | $2.20 | $2.23 | 239.28K |
| Oct 26, 2026 | $2.30 | $2.35 | $2.18 | $2.20 | 173.15K |
| Oct 23, 2026 | $2.37 | $2.65 | $2.25 | $2.30 | 137.59K |
| Oct 22, 2026 | $2.39 | $2.50 | $2.37 | $2.40 | 121.14K |
| Oct 21, 2026 | $2.53 | $2.59 | $2.39 | $2.39 | 102.62K |
| Oct 20, 2026 | $2.33 | $2.59 | $2.32 | $2.53 | 194.28K |
| Oct 19, 2026 | $2.37 | $2.47 | $2.24 | $2.32 | 118.34K |
| Oct 16, 2026 | $2.42 | $2.47 | $2.30 | $2.35 | 85.6K |
| Oct 15, 2026 | $2.37 | $2.495 | $2.28 | $2.42 | 159.38K |
| Oct 14, 2026 | $2.51 | $2.565 | $2.31 | $2.35 | 254.31K |
| Oct 13, 2026 | $2.88 | $3.08 | $2.505 | $2.515 | 185.68K |
| Oct 12, 2026 | $3.18 | $3.23 | $2.87 | $2.89 | 84.91K |
| Oct 9, 2026 | $3.23 | $3.31 | $3.13 | $3.18 | 192.5K |
| Oct 8, 2026 | $3.25 | $3.365 | $3.13 | $3.22 | 143.49K |
| Oct 7, 2026 | $3.36 | $3.46 | $3.25 | $3.27 | 106.47K |
| Oct 6, 2026 | $3.38 | $3.49 | $3.28 | $3.43 | 105.31K |
| Oct 5, 2026 | $3.30 | $3.56 | $3.19 | $3.32 | 72.36K |
Latest NERV news
The latest Smart Investors Daily articles mentioning NERV.
Stock researchCompany · Financials
Company
Market Activity
Research & News
Loading stock research…